Immune recognition of glomerular antigens

Experimental Nephrology

Volumn 8, Issue 4-5, 2000, Pages 226-234

  Phelps, Richard G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Auto immunity; Glomerular antigens; Glomerulonephritis

Indexed keywords

AUTOANTIGEN;

ANTIGEN RECOGNITION; AUTOIMMUNITY; GLOMERULONEPHRITIS; GLOMERULUS; GOODPASTURE SYNDROME; IMMUNE SYSTEM; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY INJURY; PRIORITY JOURNAL; SCAR FORMATION; SHORT SURVEY;

EID: 0033848311     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020673     Document Type: Short Survey

References (32)

1. Sun J-B, Harcourt G, Wang Z-Y, Hawke S, Olsson T, Fredrikson S, Link H: T cell responses to human recombinant acetyocholine receptor-alpha subunit in myasthenia gravis and controls. Eur J Immunol 1992;22:1553-1559.
2. Sun J-B, Olsson T, Wang W-Z, Xiao B-G, Kostulas V, Fredrikson S, Ekre H-P, Link H: Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991;21:1461-1468.
3. Derry CJ, Ross CN, Lombardi G, Mason PD, Rees AJ, Lechler RI, Pusey CD: Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin Exp Immunol 1995;100: 262-268.
4. Miller JFAP, Basten A: Mechanism of tolerance to self. Curr Opin Immunol 1996;8:815-821.
5. Lerner R, Glassock R, Dixon F: The role antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967;126:989-1004.
6. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD: Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992;89:592-60L
7. Saus J, Wieslander J, Langeveld J, Quinones S, Hudson B: Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 1988;263:13374-13380.
8. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human diseases. J Biol Chem 1993;268: 26033-26036.
9. Dunckley H, Chapman JR, Burke J, Charlesworth J, Hayes J, Haywood E, Hutchison B, Ibels L, Kalowski S, Kincaid-Smith P: HLA-DR and -DQ genotyping in anti-GBM disease. Dis Markers 1991;9:249-256.
10. Huey B, McCormack K, Capper J, Ratcliff C, Colombe B, Garovoy M, Wilson C: Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence specific oligonucleotide probe hybridisation. Kidney Int 1993;44:307-312.
11. Fisher M, Pusey CD, Vaughan RW, Rees AJ: Susceptibility to Goodpasture's disease is strongly associated with HLA-DRB1 genes. Kidney Int 1997;51:222-229.
12. Phelps RG, Rees AJ: The HLA complex in Goodpasture's disease: A model for analyzing susceptibility to autoimmunity. Kidney Int 1999;56:1638-1653.
13. Umekawa T, Kohri K, Iguchi M, Yoshioka K, Kurita T: Glomerular-basement-membrane antibody and extracorporeal shock wave lithotripsy. Lancet 1993;341:556.
14. Weber M, Pullig O, Boesken WH: Anti-glomerular basement membrane disease after renal obstruction. Lancet 1990;336:512-513.
15. Phelps RG, Turner AN: Goodpasture's syndrome: New insights into pathogenesis and clinical picture. J Nephrol 1996;9:111-117.
16. Kalluri R, Gunwar S, Reeders ST, Morrison KC, Mariyama M, Ebner KE, Noelken ME, Hudson BG: Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen. J Biol Chem 1991;266:24018-24024.
17. Kefalides NA, Ohno N, Wilson CB: Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen. Kidney Int 1993;43:85-93.
18. Hellmark T, Brunmark C, Trojnar J, Wieslander J: Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides. Clin Exp Immunol 1996; 105:504-510.
19. Ryan JJ, Mason PJ, Pusey CD, Turner N: Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Clin Exp Immunol 1998; 113:17-27.
20. Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J: Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999;55:936-944.
21. Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG: The Goodpasture autoantigcn: Mapping the major conformational epitope(s) of alpha3(iv) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 1999; 274:11267-11274.
22. Marelli-Berg F, Levy JB, Waller H, Phelps RG, Turner AN, Lombardi G, Pusey CD, Lechler RI: Characterisation of autoantigen specific T cell responses in Goodpasture's disease (abstract). J Am Soc Ncphrol 1996;7:1709.
23. Merkel F, Kalluri R, Marx M, Enders U, Stevanovich S, Giegerich G, Neillson EG, Rammensee H-G, Hudson BG, Weber M: Autoreactive T cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on α3 type IV collagen. Kidney Int 1996;49:1127-1133.
24. Matsuo H, Batocchi A-P, Hawke S, Nicolle M, Jacobson L, Vincent A, Newsom-Davis J, Willcox N: Peptide-selected T cell lines from myasthenia gravis patients and controls recognize peptides that are not processed from whole acetlycholine receptor. J Immunol 1995;155: 3683-3692.
25. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
26. Nelson CA, Roof RW, McCourt DW, Unanue ER: Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc Natl Acad Sci USA 1992;89:7380-7383.
27. Phelps RG, Jones V, Coughlan M, Turner AN, Rees AJ: Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HEA class II peptide binding preferences. J Biol Chem 1998;273:11440-11447.
28. Phelps RG, Turner AN, Rees AJ: Direct identification or naturally processed autoantigen derived peptides bound to HLA-DR15. J Biol Chem 1996;271:18549-18553.
29. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221.
30. Watts C, Lanzavecchia A: Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993;178:1459-1463.
31. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995;181:1957-1963.
32. McMichael AJ, O'Callaghan CA: A new look at T cells. J Exp Med 1998;187:1367-1371.